Shattuck Labs (STTK) Payables (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Payables of $1.3 million for Q1 2026, down 18.26% year-over-year from $1.5 million in Q1 2025, and down 40.36% quarter-over-quarter from $2.1 million in Q4 2025.
Shattuck Labs (STTK) Payables (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Payables for 8 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 18.26% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 18.26% YoY), while the FY2025 annual figure was $2.1 million, down 13.15% from the prior year.
- Payables slipped to $1.3 million in Q1 2026 per STTK's latest filing, from $2.1 million in the prior quarter.
- Across five years, Payables topped out at $7.2 million in Q4 2022 and bottomed at $475000.0 in Q2 2025.
- Historically, Payables has averaged $2.7 million across 5 years, with a median of $2.2 million in 2024.
- Annual changes were most pronounced in 2022 — Payables jumped 463.46% — and 2025, when it tumbled 83.17%.
- Shattuck Labs' Payables stood at $7.2 million in 2022, then tumbled by 77.87% to $1.6 million in 2023, then soared by 52.43% to $2.4 million in 2024, then decreased by 13.15% to $2.1 million in 2025, then tumbled by 40.36% to $1.3 million in 2026.
- Business Quant data shows STTK's Payables at $1.3 million in Q1 2026, $2.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.94 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 475,000.00 |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 5.13 Mn |
| Dec 31, 2022 | 7.17 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 5.67 Mn |
| Mar 31, 2022 | 2.59 Mn |
| Dec 31, 2021 | 10.01 Mn |
| Sep 30, 2021 | 3.25 Mn |